A study recently published in the Journal of Clinical Oncology showed revamping multi-drug chemotherapy for retinoblastoma to include tropotecan maintained high cure rates while preserving vision and reducing the risk of treatment related leukemia. Retinoblastoma ranks as the most common intraocular childhood cancer. It affects approximately 300 children in the United States each year and [..] Read More…
Castle Biosciences, Inc. recently launched a new test to help doctors better asses the risk of uveal melanoma metastasis. Uveal melanoma ranks as the most common eye cancer in adults. About half of patients diagnosed with uveal melanoma develop metastatic disease, primarily in the liver. Researchers have found gene expression levels of PRAME (Preferentially Expressed [..] Read More…
A new experimental treatment offers some hope for patients with ocular melanoma that has metastasized to the liver. Ocular melanoma is the most common eye cancer in adults. About 50% of patients diagnosed with ocular melanoma go on to develop metastatic disease. In 95% of cases, the liver is the first place metastases are discovered. [..] Read More…
A recent study published in the journal Scientific Reports appears to establish a link between certain genetic factors relating to eye color and skin pigmentation, and the risk for uveal melanoma. Uveal melanoma (UM) is the most common primary adult intraocular cancer involving the vascular layer within the eye between the retina and the sclera. [..] Read More…
Through the month of September, families, caregivers, charities, and researchers across the country observed Childhood Cancer Awareness Month. Cancer is the leading cause of death by disease in children under the age of 15. In the US alone, more than 15,000 children are diagnosed with cancer every year. While Leukemia and brain tumors are the [..] Read More…
A study published in August in JAMA Ophthalmology probes the importance of inflammation associated with immune system response in uveal melanoma. Uveal melanoma is an eye cancer that involves the iris, the muscle surrounding the lens, or the choroid – a vascular layer with connective tissue between the retina and the sclera. It is generally [..] Read More…
The American Joint Committee on Cancer (AJCC) recently celebrated the completion of the 8th edition of its Cancer Staging Manual. The AJCC Cancer Staging Manual defines an international language for oncology. Created with and adopted by the Union for International Cancer Control (UICC), the AJCC-UICC TNM Cancer Classifications enables communication between eye cancer care providers [..] Read More…
The Eye Cancer Foundation is gearing up for the Second Working Day, which is now part of the official ISOO Biennial Conference. It will commence on Friday, March 24, 2017 at the International Convention Centre in Sydney, Australia. If you’re an eye cancer specialist attending the conference, be sure to mark your calendars and arrive by [..] Read More…
The advent of smartphones and tablets has opened up new doors for patients with vision loss. In the past, they had to deal with heavy, expensive hardware in order to use assistive technology. Today, patients with vision loss can access inexpensive apps on lightweight devices that help them gain independence and better navigate the world [..] Read More…
Dr. Paul Finger and Dr. Tatyana Milman’s recently published study in the European Journal of Ophthalmology highlights the effectiveness of an innovative minimally invasive biopsy technique. Biopsy-proven iris melanoma carries a 10.7% risk of metastasis, making a safe method of iris tumor biopsy crucial. Currently, physicians often use fine-needle aspiration or wide-incision iridectomy. However, both [..] Read More…
"Very well treated by Dr. Finger. He explained everything I needed to know about my issue with detail and attention, putting me at ease and giving me confidence to handle this problem for the rest of my life.”
– N.N.
